These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 388250)

  • 1. Sodium valproate: serial monitoring of EEG and serum levels.
    Rowan AJ; Binnie CD; de Beer-Pawlikowski NK; Goedhart DM; Gutter T; van der Geest P; Meinardi H; Meijer JW
    Neurology; 1979 Nov; 29(11):1450-9. PubMed ID: 388250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of valproic acid on spike and wave discharges in patients with absence seizures.
    Villarreal HJ; Wilder BJ; Willmore LJ; Bauman AW; Hammond EJ; Bruni J
    Neurology; 1978 Sep; 28(9 Pt 1):886-91. PubMed ID: 99687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium valproate in the treatment of intractable seizure disorders: a clinical and electroencephalographic study.
    Adams DJ; Luders H; Pippenger C
    Neurology; 1978 Feb; 28(2):152-7. PubMed ID: 414151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The delayed effect of sodium valproate on the photoconvulsive response in man.
    Rowan AJ; Binnie CD; Warfield CA; Meinardi H; Meijer JW
    Epilepsia; 1979 Feb; 20(1):61-8. PubMed ID: 369854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate sodium in epilepsy. A clinical trial including monitoring of drug levels.
    Mehrotra TN; Aneja GK; Arora V; Goel S; Singh VS
    J Assoc Physicians India; 1990 Apr; 38(4):277-9. PubMed ID: 2118134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate acute administration, EEG epileptic abnormalities, and ammonemia.
    Sannita WG
    Neurology; 1992 Oct; 42(10):2003-5. PubMed ID: 1407583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex partial seizures: EEG foci and response to carbamazepine and sodium valproate.
    Gupta AK; Jeavons PM
    J Neurol Neurosurg Psychiatry; 1985 Oct; 48(10):1010-4. PubMed ID: 3932599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of significant correlation between circadian profiles of valproic acid serum levels and epileptiform electroencephalographic activity.
    Burr W; Froescher W; Hoffmann F; Stefan H
    Ther Drug Monit; 1984; 6(2):179-81. PubMed ID: 6429910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
    Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
    Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in paroxysmal activity in the EEG during valproate (Deprakine, Orfiril) therapy].
    Gulmann NC; Nielsen CJ; Christensen TL
    Ugeskr Laeger; 1981 Aug; 143(32):2035-6. PubMed ID: 6797120
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical efficacy and long-term effects of valproic acid therapy on spike-and-wave discharges.
    Bruni J; Wilder BJ; Bauman AW; Willmore LJ
    Neurology; 1980 Jan; 30(1):42-6. PubMed ID: 6765986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valproate sodium on generalized penicillin epilepsy in the cat.
    Pellegrini A; Gloor P; Sherwin AL
    Epilepsia; 1978 Aug; 19(4):351-60. PubMed ID: 100317
    [No Abstract]   [Full Text] [Related]  

  • 13. Spectral analysis of the EEG in children during the introduction of antiepileptic therapy with valproic acid.
    Benninger C; Matthis P; Scheffner D
    Neuropsychobiology; 1985; 13(1-2):93-6. PubMed ID: 3929157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of UGT2B7, SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures.
    Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2018 May; 58():96-100. PubMed ID: 29679912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytic study of epileptic absence seizures and effect of sodium valproate treatment.
    Yagi K; Morikawa T; Miyakoshi M; Kakegawa N; Osawa T; Seino M; Wada T
    Monogr Neural Sci; 1980; 5():137-41. PubMed ID: 6798425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate: quantitative EEG and serum levels in volunteers and epileptics.
    Wu X; Ma JJ
    Clin Electroencephalogr; 1993 Apr; 24(2):93-9. PubMed ID: 8500255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive follow-up monitoring in patients with once daily evening administration of sodium valproate.
    Stefan H; Burr W; Fichsel H; Fröscher W; Penin H
    Epilepsia; 1984 Apr; 25(2):152-60. PubMed ID: 6423376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium valproate: its use in primary psychiatric disorders.
    McElroy SL; Keck PE; Pope HG
    J Clin Psychopharmacol; 1987 Feb; 7(1):16-24. PubMed ID: 3102563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate reduces spontaneous generalized spikes and waves but not photoparoxysmal reactions in patients with idiopathic generalized epilepsies.
    Muhle H; Ettle E; Boor R; Stephani U; Siniatchkin M
    Epilepsia; 2011 Jul; 52(7):1297-302. PubMed ID: 21480883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice.
    Tutka P; Łuszczki J; Kleinrok Z; Arent K; Wielosz M
    J Neural Transm (Vienna); 2002 Apr; 109(4):455-66. PubMed ID: 11956965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.